Suppr超能文献

相似文献

1
Control of bone resorption in mice by Schnurri-3.
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8173-8. doi: 10.1073/pnas.1205848109. Epub 2012 May 9.
2
Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis.
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2218019120. doi: 10.1073/pnas.2218019120. Epub 2023 May 4.
3
High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
Mol Cell Biol. 2002 Sep;22(17):6222-33. doi: 10.1128/MCB.22.17.6222-6233.2002.
4
Schnurri-3: a key regulator of postnatal skeletal remodeling.
Adv Exp Med Biol. 2007;602:1-13. doi: 10.1007/978-0-387-72009-8_1.
6
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Bone. 2007 Aug;41(2):165-74. doi: 10.1016/j.bone.2007.04.190. Epub 2007 May 5.
7
Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3.
Science. 2006 May 26;312(5777):1223-7. doi: 10.1126/science.1126313.
8
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
10
Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts.
J Clin Invest. 2013 Sep;123(9):4010-22. doi: 10.1172/JCI69443. Epub 2013 Aug 15.

引用本文的文献

2
Advances in Bone-Targeting Drug Delivery: Emerging Strategies Using Adeno-Associated Virus.
Hum Gene Ther. 2024 May;35(9-10):329-341. doi: 10.1089/hum.2024.034. Epub 2024 May 3.
3
Schnurri-3 controls osteogenic fate of Adipoq-lineage progenitors in bone marrow.
J Orthop Translat. 2024 Mar 23;45:168-177. doi: 10.1016/j.jot.2024.01.008. eCollection 2024 Mar.
4
A vertebral skeletal stem cell lineage driving metastasis.
Nature. 2023 Sep;621(7979):602-609. doi: 10.1038/s41586-023-06519-1. Epub 2023 Sep 13.
5
Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis.
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2218019120. doi: 10.1073/pnas.2218019120. Epub 2023 May 4.
6
An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway.
Bone. 2023 Jul;172:116761. doi: 10.1016/j.bone.2023.116761. Epub 2023 Apr 6.
7
Discovery of a Vertebral Skeletal Stem Cell Driving Spinal Metastases.
Res Sq. 2023 Jan 25:rs.3.rs-2106142. doi: 10.21203/rs.3.rs-2106142/v1.
8
Application and Molecular Mechanisms of Extracellular Vesicles Derived from Mesenchymal Stem Cells in Osteoporosis.
Curr Issues Mol Biol. 2022 Dec 15;44(12):6346-6367. doi: 10.3390/cimb44120433.
9
WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects.
Mol Ther. 2023 Feb 1;31(2):435-453. doi: 10.1016/j.ymthe.2022.09.018. Epub 2022 Oct 3.
10
A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis.
Bioact Mater. 2021 Sep 17;10:207-221. doi: 10.1016/j.bioactmat.2021.09.015. eCollection 2022 Apr.

本文引用的文献

1
Transient muscle paralysis degrades bone via rapid osteoclastogenesis.
FASEB J. 2012 Mar;26(3):1110-8. doi: 10.1096/fj.11-196642. Epub 2011 Nov 28.
2
Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
Nat Med. 2011 Sep 11;17(10):1231-4. doi: 10.1038/nm.2452.
3
Matrix-embedded cells control osteoclast formation.
Nat Med. 2011 Sep 11;17(10):1235-41. doi: 10.1038/nm.2448.
4
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis.
PLoS One. 2011 Mar 3;6(3):e17161. doi: 10.1371/journal.pone.0017161.
5
Control of RANKL gene expression.
Bone. 2010 Apr;46(4):911-9. doi: 10.1016/j.bone.2009.08.050. Epub 2009 Aug 27.
7
Molecular mechanisms in coupling of bone formation to resorption.
Crit Rev Eukaryot Gene Expr. 2009;19(1):73-88. doi: 10.1615/critreveukargeneexpr.v19.i1.40.
10
Osteoclast-osteoblast communication.
Arch Biochem Biophys. 2008 May 15;473(2):201-9. doi: 10.1016/j.abb.2008.03.027. Epub 2008 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验